Pharmaceutical Technology via Yahoo
MHRA approves Pfizer-BioNTech’s Comirnaty JN.1 vaccine
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has authorised the use of Pfizer-BioNTech’s adapted Comirnaty vaccine to combat the JN.1 Covid-19 subvariant. The vaccine stimulates ...
39 minutes ago